期刊
CLINICS IN LIVER DISEASE
卷 16, 期 3, 页码 567-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2012.05.001
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Noninvasive; CK-18; Fibrosis; Fibrogenesis; FibroScan; Magnetic resonance elastography
资金
- NIDDK NIH HHS [R01 DK082426] Funding Source: Medline
Nonalcoholic bland steatosis and nonalcoholic steatohepatitis (NASH) are stages in the spectrum of nonalcoholic fatty liver disease (NAFLD). NASH may progress to end-stage liver disease. Liver biopsy distinguishes between patients with NASH and no NASH and can stage fibrosis. Markers of hepatocyte apoptosis hold promise as noninvasive tests for NASH diagnosis. Several scoring systems that combine routine clinical and laboratory variables and some proprietary panels can assist in predicting fibrosis severity. Noninvasive imaging modalities are reasonably accurate available tools to determine severity of fibrosis in NAFLD, but none of them yet can replace liver biopsy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据